Millenco sells 1.5 million shares of Aradigm, drops ownership to 2.7%

By Lisa Kerner

Charlotte, N.C., Oct. 2 - Investors led by Millenco LLC sold 1,505,362 shares of Aradigm Corp. stock at prices from $0.38 to $0.46 each.

The shares were sold between Sept. 17 and Sept. 30, according to a schedule 13D/A filing with the Securities and Exchange Commission.

Millenco owns 1,506,138 shares, or 2.7%, of the Hayward, Calif., company.

Aradigm develops non-invasive delivery systems for self-administration of biopharmaceuticals and small molecules.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.